Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Successful treatment with direct-acting antivirals prolonged survival by 18 months.
Those diagnosed with liver cancer after an HCV cure had a 66% lower risk of death.
People who received the vaccine did, however, show stronger immune responses against the virus.
Efforts to control viral hepatitis are falling behind, in part because of the growing opioid epidemic and homelessness crisis.
Two new interactive (and free!) databases offer maps, policies and much more, courtesy of amfAR.
Wider screening would prevent liver cirrhosis, liver cancer and the need for liver transplants.
A new study appears to resolve controversy over hep C treatment’s association with mortality risk.
Karen Hoyt promised her grandkids she would win a gold medal in the World Transplant Games. She wasn’t going to let HCC stand in her way.
Help find the “missing millions” who don’t know they’re living with viral hepatitis.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
Researchers analyzed health data regarding modern hep C treatments specific to New South Wales.
European and U.S. guidelines recommend that all those with cirrhosis undergo biannual screening for liver cancer.
People living with HIV are also facing cancer as they age.
Even positive breaking news looks different to people who know the reality of a hard-to-treat cancer.
Four things you should know to be #HepAware.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.